Skip to content

Clinical trials

Macular Degeneration trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20131
20151
20192
20201
20211
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
National Taiwan University Hospital2
Novartis2
Acer Medical Inc.1
Allergan1
Changhua Christian Hospital1
China Medical University Hospital1
Opthea Limited1
Quark Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration13
Choroidal Neovascularization3
Wet Macular Degeneration3
Diabetic Retinopathy2
Eye Diseases2
Geographic Atrophy2
Polypoidal Choroidal Vasculopathy2
Retinal Degeneration2
Retinal Diseases2
Vision Disorders2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.